Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of the Combination of Acetylsalicylic Acid and L-arginine to Prevent Preeclampsia in Pregnant High Risk

NCT02838030 is registered in ClinicalTrials.gov with University of Guadalajara as lead sponsor.

NCT NCT02838030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02838030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of the Combination of Acetylsalicylic Acid and L-arginine to Prevent Preeclampsia in Pregnant High Risk
Lead sponsor
University of Guadalajara
Phase
Phase 2
Overall status
Suspended
Start date
July 1, 2018
Completion date
August 31, 2021
Enrollment
82 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high risk pregnancy